June 26, 2024CorporateMicroVention Announces the Next Evolution in Stent Innovation: MicroVention’s LVIS™ EVO™ Intraluminal Support Device Now Available in the United StatesMicroVention Continues to Lead the Way in Innovation for both Ischemic and Hemorrhagic Stroke Treatment and Prevention
May 28, 2024CorporateTerumo Cardiovascular Announces 510(K) Clearance For The CDI OneView™ Monitoring SystemAll-new modular, expandable design displays up to 22 vital patient parameters with real-time convenience
The Latest Materials Financial Results for FYE 3/2024 May 14, 2024 Financial Statements IFRS Financial Results for the Fiscal Year Ended March 31, 2024 (PDF 482.92 KB) Presentation Material The Future of Terumo "Our vision and the path to it" (PDF 1.54 MB) Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023) (PDF 1.38 MB) Financial Results for the Fiscal Year Ended March 31, 2024 (FY2023)(with note) (PDF 769.2 KB) Additional Information Corporate Data File (PDF 615.46 KB) Corporate Data File (Excel 390.96 KB) Q&A Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024 (PDF 161.49 KB) Webcast Listen to the Webcast Financial Statements /investors/library/financial-statements Presentations /investors/library/presentations Terumo Report /investors/library/annual-reports Sustainability /sustainability Corporate Governance /about/governance Consolidated Financial Statements /investors/library/financial Adobe Reader is required for viewing PDF files. Download Adobe Reader
Q&A Session at the Financial Results Briefing for the Fiscal Year Ended March 31, 2024 (PDF 161.49 KB)